Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 23, 2019- Panel titled "Digital Therapeutics Deliver Evidence-based Results: The Example of DarioHealth"
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth's Chief Executive Officer, will be a...
-
Sep 18, 2019- U.S. patent supports the development and implementation of paired smartphone devices to collect and analyze real-time medical data
DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and...
Sep 11, 2019- Dance Biopharm signs an agreement with DarioHealth to integrate Dance's gentle mist smart inhaler into DarioHealth's platform allowing for automated, real-time treatment data through a mobile applicationDance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced today it has formed a strategic alliance with DarioHealth...
-
Aug 28, 2019
Leading global digital therapeutics company DarioHealth Corp. (Nasdaq: DRIO) today announced that DarioHealth's Chief Executive Officer, Erez Raphael, will present to and meet with investors and...
-
Aug 15, 2019- DarioHealth's innovative digital therapeutics solutions will assist the UK National Health Service with managing chronic health conditions, such as diabetes and hypertension
DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London ("DH.L") as part of its UK Israel...
-
Aug 13, 2019
Q2 2019 Revenue of $1.65 million, a 20% decline from Q2 2018 Record 1H 2019 Revenue of $3.89 million, a 2% increase over 1H 2018 Expense shift from D2C to B2B, resulting in a short-term decline in...
-
Aug 12, 2019Dario Membership users with diabetes achieved a 39% increase of in-range, blood-glucose measurements
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators...
-
Aug 7, 2019Earnings Discussion and Business Update Scheduled for 9:00 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its second quarter 2019 results on Tuesday, August 13, and host a conference call the...
-
Aug 6, 2019- Data further underscores clinical evidence of overall health improvement for type 2 Diabetes users of DarioHealth app
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to...
-
Jul 30, 2019New offering enables users to integrate blood pressure readings into the Dario mobile app to gain better understanding and control of overall health.
DarioHealth Corp. (Nasdaq: DRIO), ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app...
-
Jul 25, 2019DarioHealth offers USB-C connector configuration between Android smart mobile devices and the Dario Blood Glucose Meter
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today announced that its CE certificate covers a USB-C connector enabled version of the acclaimed Dario™ Blood Glucose...
Jul 8, 2019Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced that on July 5, 2019, it received notification from Nasdaq that the Company has been granted an additional...
-
Jun 11, 2019Digital Therapeutics leader DarioHealth caps off successful week at the ADA with Two Studies Presenting New Real-World Data in the Field of Diabetes
DarioHealth Corp. (NASDAQ: DRIO), a leading global Digital Therapeutics (DTx) company with connected devices, mobile software and large data solutions presented two studies reporting new...
-
Jun 4, 2019
Functional Medicine Center of Fort Collins, in Fort Collins, CO will incorporate Dario's digital diabetes platform to its health and wellness improvement programs NEW YORK, CAESAREA, Israel and...
-
May 29, 2019Outcomes of several new studies to be released, demonstrating improved life with diabetes.
Global digital therapeutics (DTx) innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced its participation at the annual conference of the American Diabetes Association (ADA) in San Francisco on
-
May 22, 2019
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced the pricing of an underwritten public offering of 4,855,341 shares of...
-
May 21, 2019
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced that it intends to offer and sell shares of common stock (or pre-funded...
-
May 13, 2019- Earnings and business update call scheduled for 9:00 am ET today
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the first quarter ended March 31, 2019. CEO, Erez Raphael,...
-
May 7, 2019Earnings Discussion and Business Update Scheduled for 9:00 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its first quarter 2019 results on Monday, May 13, and host a conference call the same...
-
May 3, 2019DarioHealth's mission is to support people with diabetes and other chronic conditions in the U.S. and around the world. Dario is proud to align its efforts with those of the American Diabetes Association (ADA) to increase awareness of diabetes and its risk factors, and to support those living with diabetes and their loved ones
Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is partnering with the American Diabetes Association as a Living Red Sponsor of NYC - Step Out®:...
- Apr 30, 2019Dario's mission is aligned with the DTA's mission of improving healthcare quality, outcomes, and value through optimizing the use and integration of digital therapeutics
Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is now a member of the Digital Therapeutics Alliance (DTA) (www.DTxAlliance.org). Dario's...
-
Apr 10, 2019New version V4.2.0 is a testament to Dario's relentless commitment to patients with chronic conditions.
Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced the launch of a new version of its acclaimed Dario® system and DarioEngage™ platform. The enhancements...
-
Apr 1, 2019The 'Per Engaged Member Per Month' (PEMPM) model is value-driven, simple and effective to cover the needs of providers and their patients
Global #digitaltherapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an agreement with Cupertino-based Auer Integrative Health's Functional Medicine and Chiropractic, a Silicon...
Mar 27, 2019The Dario® Blood Glucose Monitoring System will be made available to hospitals and health systems using Glytec's virtual insulin titration service for outpatients with diabetesGlobal digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for...
-
Mar 25, 2019Conference Call Scheduled for 9:00 am ET today
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the full-year ended on December 31, 2018. Financial Highlights...